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ABSTRACT 
 
Ebrahimian, Venus.  M.S., Department of Pharmacology/Toxicology, Wright State 
University, 2013.  Characterization of Red Diamondback Rattlesnake protein on Cell 
Death and Function. 
 
Snake venom is composed of many different toxins and protein components such 
as metalloproteases and phospholipase A2.  Together, these proteins cause an up 
regulation in cell death pathways and disrupt the overall homeostasis of a living cell.  The 
Red Diamondback Rattlesnake is abundantly available and well-known specie and has 
been used as a source for development of new drugs.  It has been mainly used for the 
purposes of making anti-venom but it has also been therapeutically used for surgical 
purposes to act as an anti-aggregate.  Integrins derived from RDB venom has been used 
for cancer cell treatment as well.  Specifically a hemotoxic venom, RDB venom contains 
high concentrations of the toxin Ruberlysin; also known as Hemorrhagic Toxin II.  An 
animal or human bitten by a RDB snake will experience localized tissue swelling, pain, 
bruising, as well as necrosis at the bit site.  Systematically, the venom will cause excess 
internal bleeding, nausea, vomiting, and due to being hemotoxic venom, it will cause 
hemolysis.  Due to its rich protein content as well as possible therapeutic purposes, RDB 
venom proves to hold the potential for studying cancer.  The purpose of this research is to 
test the  effects of Red Diamond Back rattlesnake venom protein components on different 
neuronal and lung cell lines, identify specific protein components and determine the 
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venom’s effects on specific cellular functions, i.e., intracellular prohormone trafficking 
and surfactant lipid secretion.  To understand how the venom components work, the 
venom was fractionated by Fast Protein Liquid Chromatography and desalted through 
membrane dialysis using ddH2O.  Neuro-2A and lung  cells were incubated  with 
individual snake venom fractions at different concentrations and over a 6 hour time.  
After analysis by specific cell death assays, i.e., MTT, LDH, propidium iodide, annexin 
and Hoechst, several specific fractions were observed to cause cell death, while other 
fractions appeared to cause an increase in proliferation. Furthermore, chromogreanin A 
trafficking to punctate granules characteristic of the regulated secretory pathway was 
disupted in the Neuro-2a cells. Likewise, secretion of surfactant lipids appeared to be 
enhanced for several lipids from the lung cells exposed to snake venom fractions. 
Specific RDB venom protein fractions were tryptically digested, spotted to a MALDI-
target and sequenced using a Bruker Autoflex III MALDI TOF/TOF mass spectrometer.  
Ion data was collected and sent to an in-house MASCOT server database, which 
identified Hemorrhagic toxin (II), myotoxin, and apoxin I. The results from our study 
suggest that FPLC-cation exchange is a good first pass scheme for separating snake 
venom proteins, and that these separated proteins appear to have unique characteristics 
for cell death, proliferation and functionality.  
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I. STATEMENT OF THE PROBLEM 
The phenotype of cells is defined by functionality conferred by the expression of 
specific proteins. The growth and proliferation of cells varies depending on the different 
types of cells and their functions. Sometimes, the regulation of growth, proliferation or 
functionality is lost, resulting in a tumor or cancer type of cell. The problem is that these 
cells have lost their regulation and form the foci of a disease called cancer. Over the past 
century, numerous treatments have been developed to try to bring these cells under 
regulation or to remove them. Some treatment therapies are more effective than others 
and some are more invasive and life-threatening themselves than others. The goal is to try 
to re-regulate the cellular function or to stop or slow the proliferation of the cells so that 
the tumor or cancer does not progress without creating a worse condition for the patient. 
The goal of our research is to identify specific proteins from snake venom that act by one 
of these mechanisms. Lung cells derived from biopsy samples of hospital patients 
afflicted with adenocarcinoma and neuroblastoma cells from mouse neural crest were 
used to test the snake venom proteins.  
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II. INTRODUCTION 
THE RED DIAMONDBACK RATTLESNAKE 
The red diamondback rattlesnake (RDB), also known as crotalus ruber ruber, is a 
heavy set and somewhat docile snake belonging to the Viperidae family.   The versatile 
nature of this particular snake is further proven by its presence in islands in the Gulf of 
California and along the pacific coast of Baja California [Dugan, 2012].  RDB is often 
misidentified as the Western Diamond-backed Rattlesnake, although the habitats of these 
two snakes never converge to make such confusion possible and thus is attributed to the 
physical characteristics of the snakes.  RDB has a prominently triangular head and is a 
relatively large sized snake, reaching approximately between 2-4.5 feet in length with 
characteristic shades of red that give root to its namesake [Dugan, 2012].  Like many 
other snakes in the Viperidae family, RDB has a rattle, growing larger with each 
shedding that the snake goes through and giving the characteristic rattling sound that the 
snake makes when offering a warning.  The snake has movable and retractable fangs, 
which are intricately connected to venom glands that produce venom throughout the 
course of the snake’s lifetime.  Mode of reproduction for this particular snake is through 
live birth and baby snakes are left to fend for themselves upon birth.  Their diet consists 
mainly of small mammals such as ground squirrels, rats, rabbits, lizards and sometimes 
birds [Dugan, 2012]. There have been reports however, that adult ground squirrels are 
immune to rattlesnake venom and will aggressively confront the snake should they feel 
threatened [Biardi, 2006].  Although less venomous than its close relatives, the venom of 
the RDB has been identified as a hemotoxic venom.  Hemotoxic venom contains 
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components that mainly disrupt the homeostasis of red blood cells within the afflicted 
patient or prey, leading to systemic hemolysis [Panfoli, 2010].    
SNAKE VENOM 
Snake venom type and potency is characterized based upon many characteristics, 
e.g., specie, geographical location, habitat, climate and age, etc. All snake venom share 
many components that are found to be the same through species with some comprising a 
larger proportion of the mixture than others.  Thus, snake venom consists of a complex 
and unique mixture of proteins, peptides, polypeptides, peptidases, hydrolytic enzymes, 
metals and etc [Fry, 2005].  Each of these components not only makes venom uniquely 
different but also, provides a special functionality characteristic of the particular snake.  
Most components found within venom are heavily involved in the incapacitation of the 
prey of interest for that particular snake.  Once the prey has been subdued, proteins found 
in snake venom aid in the digestion of the prey for the snake [Fry, 2005].  Based upon the 
method of hunting as well as toxin and enzyme components, snake venom can be 
categorized as either neurotoxic or hemotoxic, although there are certain snake species 
that have both types of toxins present within their venom.   
RDB venom contains high levels of proteolytic enzymes that are mainly active as 
on blood cells, thus categorizing it as a hemotoxic venom.  The most common protein 
component observed in RDB venom has been ruberlysin, a metalloprotease commonly 
known as Hemorrhagic Toxin II [Mori, 1987].  Hemotoxic venoms act by destroying red 
blood cell membrane components as well as other surrounding vascularized tissue in the 
process; thus leading to severe tissue necrosis and blood coagulation.  Other prominently 
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found proteins in RDB venom include: apoxin, phospholipase A2, annexin as well as 
apoptosis inducing factors (AIF) [Joshi, 2012].  Apoxin is a recently discovered apoptosis 
inducing factor (AIF) that is found abundantly in snake venom [Torii, 1997].  
Phospholipase A2 is an anti inflammatory protein that is found ubiquitously in all snake 
venom [Mackessy, 2009].  And lastly, Annexin is known as an anti coagulant inducing 
protein that is found broadly in all organisms including fungi [Braun, 1998].   
CANCER  
Cancer, by definition, refers to the unmitigated corruption of normal cellular 
division.  Regulatory pathways that ensure normal cellular angiogenesis are interrupted 
by various factors and cause malignant cells to not only have compromised tumor 
suppressor genes but continue to divide, passing on the altered genetic material to future 
cells and forming what is known as tumors in the affected tissue.  Causes of tumor 
angiogenesis can vary from environmental factors such as exposure to certain chemicals 
or UV light to mishaps during mitotic division [Weinberg, 2013]. The current methods 
used in cancer treatment are somewhat effective and mainly use chemicals that not only 
destroy the tumor cells but also healthy cells around the effected area as well.  These 
treatments include the use of different forms of chemotherapy using alkylating agents, 
topoisomerase inhibitors, and cytotoxic antibiotics to name a few.  The toxicity of 
chemotherapy is a factor underlying why many cancer patients do not survive this form 
of therapeutic treatment.  Another method involves surgically removing an effected area 
in a given organ.  This surgery is most effective if the organ is affected in a specific area 
that can be easily removed.  The prognosis of this form of cancer treatment depends on 
type as well as the stage of cancer  [Cancer.org, 2013].  And lastly, radiation, which 
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usually accompanies the other listed forms of cancer treatment.  These three methods 
have proven to be the most effective forms of treatment of cancer despite the implications 
that accompany the treatment itself as well as the type of cancer.   
CELL DEATH 
 There are two well-known cell death pathways: apoptosis and oncosis (Majno, 
1995).  Unlike oncosis which usually involves cellular trauma that leads to an 
irrecoverable injury such as nucleic changes and structural disruption causing cell death; 
apoptosis is programmed cell death that occurs cyclically when an error is made during 
the life cycle of that particular cell.  Apoptosis is genetically controlled and is initiated 
based on the length of cell cycle under normal circumstances; other chemical and 
physical agents, hormones, and viruses can induce programmed suicide in the cell (Buja, 
1993; Majno, 1995).  Involving a signal pathway, any change during cell growth will 
cause the cell to go through apoptosis to prevent the passing on of any erroneous genetic 
material.  To ensure the prevention of any such mistake, there are several proteins as well 
as tumor suppressor genes that check for DNA normalcy and will induce programmed 
cell death should there be any mismatching or other errors in cellular development.  The 
morphology of apoptotic cells is as followed: blebbing, chromatin condensation, cell 
rounding and loss of processes, shrinkage of cell bodies, and cleavage of DNA into 180 
base pair segments (Buja, 1993; Majno, 1995).  Once the cell has died, its organelles and 
body are packaged and then phagocytized by macrophages present within the tissue (Buja, 
1993; Majno, 1995).    Oncosis morphology involves cell swelling, loss of identity, 
rupturing and leakage of cell content and inflammation due to the presence of cytokines 
into the extracellular matrix (Majno, 1995).  Once the cell has died, it follows the same 
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pathway as that of apoptotic cells in that their cellular content are packaged and then 
phagocytized by macrophages.  A tissue is considered necrotic after the cells have gone 
through apoptosis or oncosis; a postmortem effect rather than a presently observable 
change (Majno, 1995).   Due to the fact that both cell death methods lead to necrosis, it is 
best to use several different test methods to identify exact method of death amongst cells.  
Due to apoptosis being programmed, different markers can be used that are only 
characteristically present when the cell commits suicide.  The P53 protein, as well as 
different caspases that act as “toll booths” during cell suicide, can be used as markers to 
identify cells going through apoptosis.  In this study, LDH assay as well as MTT assay 
were used to detect the presence of lactate dehydrogenase which is indicative of cell 
damage as well as cell enzyme activity and cell proliferation to identify whether or not 
venom treated cells are going through apoptosis or oncosis respectfully.  Alternatively, 
proliferation is the reverse of apoptosis and oncosis.  Cells are programed to increase in 
number, leading to division and growth.  This occurs amongst normal cells that contain 
genetic material that have passed through the signal pathway with flying colors.  
However, cellular proliferation is observed amongst mutated cells such as those found 
containing oncogenes.  The purpose of this form of proliferation is to pass on as much of 
the tampered genetic material as possible.  Cells are programmed to continue 
proliferating instead of committing suicide.   
VENOM AS THERAPEUTIC AGENT 
The most far-reaching objective of snake venom studies has been in their use for 
therapeutic purposes.  The use of an isolated protein from naturally produced substance 
such as venom that can be readily found in nature may be an interesting and exciting 
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alternative to synthetic SAR types of drug production.  No matter what snake, the venom 
they produce is complex. Some proteins are even produced by bacteria that reside in the 
glands. To be able to properly identify proteins from snake venom requires understanding 
the chemical characteristics of the venom. Venoms from a wide array of animals 
including but not limited to snakes have been used for therapeutic purposes in medicine 
and are actively used today.  Cobra venom has been widely used as an anticoagulant in 
stroke patients as well as cardiovascular surgeries [Kini, 2006]. Biomedical engineers at 
Washington University have discovered that alterations in an inflammatory protein found 
in bee venom, i.e., mellitin, can be used as a therapeutic drug delivery system for cancer 
treatment (Soman, 2009).. Bee venom has also shown anti-cancer effects in prostate 
cancer cells through the caspase pathway activation .  It does so by inducing apoptosis in 
cells through several pathways such as activation of caspases as well as matrix 
metalloproteinases (Soman, 2009). Venom derived from cone snails found in the sea has 
shown potential cytotoxic activity in Ehrlich’s ascites carcinoma cells by inducing 
oxidative stress [Abdel-Rahman, 2013].  Sea anemones are also currently a new topic of 
interest in cancer studies and according to Ramezanpour et al,  the venom of 5 types of 
sea anemones were tested on A549 lung cancer, T47D breast cancer and A431 skin 
cancer cells and were proven to be effective as anti-cancer agents [Ramezanpour, 2012].  
Bufalin, a toxin extracted from the skin secretions of the Chinese toad, has shown anti- 
cancer activity by inducing apoptosis in various cancer cells such as colon cancer and 
hepatocellular cancer cells.  However, snake venom appears to show the most therapeutic 
promise in oncological diseases.  This may be due to its abundant availability as there are 
still various species of snake being discovered today.  Venom toxin derived from Vipera 
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Lebetina Turanica caused ROS- and JNK-mediated upregulation of death receptors in 
cancer cells, thus down regulating survival proteins in these cells [Park, 2012].  Zhang et 
al. isolated ACTX-6 from the venom of Agkistrodon acutus snake, and found that upon 
exposure, it can cause apoptosis involving ROS [Vyas, 2013].  Torii et al found an 
apoptosis inducing factor, Apoxin I from rattlesnake venom that can be therapeutic [Torii, 
1997].  Tang et al discovered that MHCC97H cells are inhibited from metastasis by 
cystatin; a protein found in snake venom that reduces proteinase activity and epithelial 
mesenchymal transition [Tang, 2011]. A disintegrin known as contortrostatin, found in 
the venom of the southern copperhead Agkistrodon contortrix contortrix was identified at 
the University of Southern California Keck School of Medicine to cause a blockage in the 
cellular migration and communication in human breast and ovarian cancer cells [Zhou, 
1999].  When injecting tumors with the disintegrin, it was noted that the tumor 
angiogenesis was significantly inhibited [Zhou, 1999].  These previous venom studies 
represent varied and important chemical pathways that may be the future of curing 
specific diseases such as cancer, diabetes and Alzheimer’s. However, much work needs 
to be done to characterize specific venom proteins and properties before this can happen.    
NEUROBLASTOMA CELL LINE 
Neuro-2A cells are neuronal and amoeboid stem cells derived from readily 
occurring neuroblastoma tumors in an albino strain A mice [ATCC].  The cells are 
characterized by their production of microtubule protein, numerous secretory vesicles and  
acetylcholinesterase which may come in use during signal transduction in neuronal cells 
[ATCC].  They were originally grown isolated into in vitro culture in 1967 [Jorgensen, 
1976]. The cells grow in the form of monolayer that is adherent [ATCC].  When cultured, 
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they tend to grow rapidly and form cellular extensions known as neurites  [Jorgensen, 
1976; Cool, 1994; Cool 1995].  These cells were chosen because they have a regulated 
secretory pathway that is representative of neuroendocrine cells in the pituitary and they 
have been well-characterized previously in other studies [Jorgensen, 1976]. They 
endogenously produce pro-enkephalin and prohormone convertase 1/3 and prohormone 
convertase 2 [Bamburger, 1995]. For this reason, they have been used as a model cell line 
for studying the intracellular trafficking of prohormones such as pro-opiomelanocortin, 
pro-insulin and pro-vasopressin [Cool, 1995; Norment, 1997; Cool, 2008; Yan, 2010].  
ADENOCARCINOMA CELL LINE 
The lung cells (NCI-H441) are derived from a human adenocarcinoma and were 
obtained from ATCC. Not composed of just one specific cell line, this particular 
tumorigenic cell line is composed of 7 lung cancer cell lines with different degrees of 
genomic mutation at varying levels [ATCC].  Mainly, these cells are used for 
understanding genetic mutations, cancer inducing genes as well as exposure to varying 
substances and chemicals for treatment purposes [ATCC]. Of interest for this project was 
the function of the lung cells to secrete surfactant. Surfactant is critical for lung function 
as it provides the correct environment for the lung cells to stay ‘open’ without collapsing 
and disrupting air flow in and out. In an earlier study (Retzke & Cool, personal 
communication) the lung cell line was used to test differences in surfactant secretion in 
response to 24 and 48 hour treatment with dexamethasone, a corticosteroid that is used to 
mature the lungs of fetuses that may be delivered early [Platzker, 1975]. Lung surfactant 
is a complex mixture of proteins, e.g., surfactant protein A, B, C, or D, and lipids, e.g., 
lecithin and sphingomyelin (Figure 1A & B). Fetal lung maturity is determined in clinical 
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labs as a ratio between the lecithin and sphingomyelin (LC:SM). A ratio of 2:1 LC:SM is 
considered mature enough for delivery. Lecithin is usually a mixture of different 
phospholipids with a major component identified as phosphatidylcholine [Liu, 1998].  
 
Figure 1: Structures of Lecithin (A) and Sphingomyelin (B).  These are two of the main 
lipid components of lung surfactant.  
FPLC VERSUS COLUMN CHROMATOGRAPHY 
This project involved the use of a common protein separation technology that had 
not previously been used for separating snake venom proteins. Specifically, RDB snake 
venom was separated into fractions using Fast Protein Liquid Chromatography (FPLC) 
followed by desalting using dialysis membrane.  We have used a cation exchange column 
on the FPLC to separate the snake venom. Cation columns are an affinity type of column 
that have a negative charge on the stationary phase (beads). Positively charged analytes 
(proteins) are bound to the column and eluted by an increasing salt gradient under a 
stable pH. While cation exchange FPLC separates proteins, it does not provide a high-
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resolution separation whereby each protein is found in a separate fraction. This tends to 
be a ‘first-pass’ type of technology but one that yields a level of protein separation with 
some fractions containing multiple proteins. This can also be done in a relatively short 
period of time, i.e., less than 20-30 minutes compared with the older column 
chromatography methods that can take more than 24 hours to complete a run [Sheehan, 
2004]. Column chromatography can yield higher resolution separation of individual 
proteins but it comes at a cost in time and starting material. Column chromatography 
typically uses several large columns packed with separating matrices that require a cold 
room or cold cabinet at 4°C and several days to run. Future FPLC work will include a 
sizing column which would provide a better first pass separation of protein.  
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HYPOTHESIS 
 The hypothesis is that isolated rattlesnake venom proteins can slow cell 
proliferation, or cause cell death in neuronal or lung cells. Furthermore, we hypothesize 
that some fractions can disrupt specific cell functions such as intracellular protein 
trafficking or release of lipids such as surfactant.  
SPECIFIC AIM 1 
Test the hypothesis that snake venom fractions can slow proliferation or cause cell death 
in lung cells or neuroblastoma cells. 
SPECIFIC AIM 2 
Test the hypothesis that cell functionality can be disrupted by specific snake venom 
proteins obtained by fractionation. 
SPECIFIC AIM 3 
Identify proteins in individual snake venom fractions and relate these to pathways 
involved in regulation of the cellular functions. 
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III. MATERIALS & METHODS 
CELL LINE 
 Neuro-2A cells obtained from ATCC were originally cultured from the 
neuroblastoma tumors in albino strain A mice. The. lung cell line (NCI-H441)  was also 
obtained from ATCC and was originally derived from patient biopsy samples of a human 
adenocarcinoma.  The cells were grown and incubated following ATCC protocol.  Briefly, 
the Neuro-2a cells were grown in DMEM media containing 10% FBS, 1X pyruvate, 1 X 
NaBicarbonate, and 1X PenStrep Fungizone. They were passaged when 80-90% 
confluent and maintained at 37°C and 5% CO2. The CI-H441 lung cells will be grown in 
Waymouth’s MB571/5 medium (Invitrogen) containing 2% Charcoal-stripped FBS 
(Hyclone) and 1.5% antibiotic/antimycotic (Cellgro; containing 10,000 unit/ml penicillin 
G sodium, 10,000 ug/ml streptomycin sulfate, and 25 ug/ml amphotericin B).   
VENOM 
Raw RDB venom was acquired from red diamondback rattlesnakes kept in the 
WSU Laboratory Animal Resouces facility under an approved protocol.  Snakes were 
milked from each fang separately prior to feeding and the venom was put into test tubes 
indicating if venom was acquired from the left or right fang of the animal.  Upon 
acquiring venom, it was stored at -4°C until further use. 
VENOM FRACTIONS 
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Venom was fractionated using Fast Protein Liquid Chromatography (FPLC).  
Mobile phase was at 0-1 M NaCl over a 13 minute run time with a 25mM MES buffer at  
pH 8.  The FPLC was set to run at 4 mls/min and 1ml fractions were collected.  Fractions 
were then desalted using 1000 dalton cutoff dialysis tubing (Spectrum, Fisher Scientific).  
Fractions were dialyzed 4 hours changing the ddH2O every hour. Upon desalting, each 
fraction was moved to a 1.5 ml eppendorf tube and stored at -20°C until further use. 
CELL TREATMENT 
 Both cell types were plated in 8 and 24 well plates at a ratio of 25 ul of cells and 
700 ul of complete media per well.  Cells were treated upon reaching 80% confluency.  
The neuro-2a cells took approximately 2 days to reach that level of confluency while lung 
cells typically took 3-4 days.  Cells were initially washed with media minus phenol red 
and FBS in a sterile environment before treatment.  The snake venom concentration used 
was fixed at 100 µl of fraction combined with 700 ul of phenol red free media which was 
then used to treat each well with 200 µl of snake venom fraction-media mixture.  A 
fourth well was given 200 µl of fraction-media mixture and the plates were returned to 
the incubator for 4 hours. Once the treatment was completed, if wells contained 
coverslips, they were fixed using 4% paraformaldehyde (PFA).  Wells containing no 
coverslips were analyzed for fraction functionality using different assays based on cell 
type. Depending on analysis method, cell media from different treatments were collected 
and stored at -4°C until further use.   
MTT ASSAY 
15	  
 Cellular proliferation post fraction treatment was detected using the TACS® MTT 
Cell proliferation Assay Kit (Molecular Probes Inc, Eugene, OR).  The cells were seeded 
into 96 well flat bottomed cell culture plates at a density of 10,000 cells per well and 
allowed to grow overnight at 37°C and 5% CO2. On the second day, the media was 
removed from the cells, the media replaced with phenol free and FBS free media 
containing the appropriate concentrations of snake venom fraction, and incubated for four 
hours at 37°C, 5% CO2. Following incubation, 10 µl of MTT reagent was added to the 
media on the cells and returned to the incubator for 2-4 hours until a purple dye was 
visible. At that time, 100 µl of detergent reagent was added to the wells, for an overnight 
incubation at room temperature. The following day, the absorbance in each well was 
measured on a Packard Fusion Plate Reader at 570 nm. Data was averaged and the blank 
subtracted from the total. The results were graphed in Excel as absorbance vs time or 
concentration.  
LDH CYTOTOXICITY ASSAY 
Cellular damage from treatment was detected using the LDH Cytotoxicity 
Detection Kit (Clontech, Mountain View, CA). The catalyst was prepared by 
reconstituting the lyophilate with 1ml of distilled water.  The dye solution consisted of 
INT solution that became readily available upon thawing.  A reaction mixture was 
prepared based on the number of tests conducted: for 100 tests 250 µl of catalyst solution 
was mixed with 11.25 ml of dye solution before use.  Duplicate wells were designated for 
controls as followed: a background control which contained 200 µl of assay medium, 
substance control I which contained 100 µl of test substance  at the max concentration 
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used for experiment with 100 µl /well assay medium, low control for spontaneous LDH 
release which contained 200 µl of assay medium and finally, a high control for maximum 
LDH release which contained 100 ul of assay medium and 100 µl of Triton X-100 
solution. The wells containing cells were pipetted repeatedly until cells detached.  
Solution containing cells were transferred to ependorf tubes and were centrifuged at 250 
x g for 10 min.  The supernatant was carefully removed without disturbing the formed 
cell pellet and transferred into labeled wells in a new 96-well-flat bottom plate.  100 ul of 
reaction mixture was then added to each well and incubated for approximately 30 min in 
an area void of light.  The absorbance of the samples at 495 nm was done using a multi 
well plate reader.  Percent cytoxicity is calculated by using the following formula: 
  Cytotoxicity (%) =     Duplicate Absorbance – Low Control x100 
     High Control – Low control 
For control cells, 100 µl was added to the media in place of snake venom fractions.  
PROPIDIUM IODIDE STAINING 
Propidium iodide (PI) staining is typically used to distinguish between living and 
non-living cells by intercalating PI into double stranded nucleic acids such as the DNA of 
the dead cells and emitting a red fluorescence that is ideally detectable by a fluorescence 
microscope.  This stain is only permeable through the cellular membrane of dead or 
dying cells, this allows for death rate analysis.  The protocol was followed per the 
discretion of the staining kit (Calbiochem, San Diego, CA).  PI is dissolved in PBS buffer 
containing PBS at a concentration of (1 µg/ml).  The solution is made in the dark. with 
the least presence of light.  Cells are washed with PBS and treated with the stain and then 
fixed on slides and kept in a dark area over night.   
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CHROMOGRANIN STAINING 
Cells were fixed with 2% paraformaldehyde (Electron Microscopy Sciences)  and 
0.1% Triton X100 for 30 min and blocked with 10% goat serum in PBS for 1 hour, 
followed by incubation with antibodies to chromogranin A (1:250 ). Chromogranin A 
antibodies were purchased from ICN.  After incubation, the cells were incubated with 
goat anti-rabbit IgG conjugated to biotin followed by incubation with streptavidin 
conjugated Texas Red (Roche, Indianapolis, IN). The coverslips were affixed to slides 
with GelMount mounting media (Biomeda, Foster City, CA) and images taken using a 
Leica digital camera system on a Leica DMR fluorescence microscope.  
ANNEXIN AND HOECHST STAINING 
 Cells were fixed with 2% paraformaldehyde in PBS for 15 minutes.  They were 
washed with PBS two more times before being mounted. Cells were initially washed with 
1xPBS.  They were then treated with Annexin diluted at 1:250 in 5 mls of 10% goat 
serum for 1 hour.  Cells were then gently washed with PBS for give minutes, 3 times.  
They were then washed once with deionized water. Hoechst 33258 stain (1 µl) was 
combined with 10 ml of deionized water and added to the cells for 1 minute.  Excess stain 
was then rinsed away using deionized water. mounting on slides.  
THIN LAYER CHROMATOGRAPHY (TLC)  
Thin layer choromatography (TLC) was used for the detection of surfactant in 
treated lung cells. A 9:1 ratio of chloroform to methanol was added to the wells of treated 
cells at equal volume.  Contents of the wells were transferred to eppendorf tubes and 
vortexed for 30 seconds.  They were then speed vacuumed for 3 minutes and the 
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supernatant was removed.  The white lower organic phase was then dried using the speed 
vacuum.  The contents were resuspended in a small volume 50 ml of methanol and 
HPTLC Silica Gel 60F254 plates (EMD, Gibbstown, NJ) spotted with 5 microliters of the 
extracted lipids. The HPTLC plates were resolved by running in a closed glass tank 
containing a mixture of: chloroform:methanol:acetic acid:acetone:ddH2O at a 51:32:9:5:3 
ratio.  When the solvent front reached ~0.5 cm from the top of the HPTLC plate the HP-
TLC plate was air-dried and sprayed with a mixture of primuline in water at a 
concentration of 1 mg/ml and air-dried. The primuline stained plates were examined 
under a DyLight 488 setting on the ChemDoc MP imaging camera (Bio-Rad, Hercules, 
CA) for 1 second to 10 seconds and the best image saved for evaluation.  
IMAGE CAPTURE 
Stained cells were visualized on a Leica DMR epifluoresecent microscope and 
images were captured using a Leica CCD digital camera system.  These images were 
prepared for publication using Adobe Photoshop and Adobe Illustrator CS3 software.  
Non-stained cells were visualized on a light microscope. 
MASS SPECTROMETRY 
 Snake venom fractions causing the most change in cell functionality were further 
analyzed using mass spectrometry.  Fractions were digested using an in-solution tryptic 
digest. The material required for the preparation of the digest was: a trypsin stock, a 
digestion buffer composed of ammonioum bicarbonate that is dissolved in ultra pure 
water to a 50 mM concentration, a reducing buffer consisting of DDT that is dissolved in 
ultra pure water to a 100 mM concentration, and an alkylation buffer prepared from 
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Iodoaceamide, also dissolved in ultra pure water to a 100 mM concentration. Shortly 
before use, dilute 2 µl trypsin working solution with 18 µl of Digestion Buffer (25 mM 
ammonium bicarbonate) for each sample being processed.  Concentration will be ~10 
ng/µl (for a total of 200 ng in 20 µl).  Store activated trypsin on ice until use.	  	  
Reduction	  and	  alkylation.	  	  
Reduction	  solution	  was	  made	  by	  adding	  15	  µl	  of	  digestion	  buffer	  and	  1.5	  µl	  of	  
reducing	  buffer	  to	  a	  0.5	  ml	  eppendorph	  tube.	  Add	  10	  µl	  of	  protein	  to	  this	  tube	  and	  
adjust	  to	  27	  µl	  with	  ultrapure	  water.	  The	  tube	  was	  incubated	  at	  95°C	  for	  5	  minutes	  
then	  allowed	  tube	  to	  cool.	  After	  this,	  3	  µls	  of	  alkylation	  buffer	  was	  added	  to	  the	  
sample	  reaction	  and	  incubated	  in	  the	  dark	  at	  room	  temperature	  for	  20	  min.	  	  For	  
digestion,	  	  5	  µl	  of	  the	  trypsin	  stock	  was	  added	  to	  45	  µl	  of	  the	  digestion	  buffer.	  From	  
this,	  1	  µl	  of	  the	  trypsin	  in	  digestion	  buffer	  was	  added	  to	  the	  reaction	  tube	  and	  
incubated	  at	  37°C	  overnight.	  
After digestion, cells were zip tipped to remove any remnants of salt. ZipTip- A 
C18 ZipTip was activated by pipetting methanol 3 times up and down, and washed by 
pipetting 0.1% TFA 3 times. The sample was pipetted up and down 5 times, followed by 
washing with 0.1% TFA, and elution with 20 µl of 95% acetonitrile containing 0.1%  
TFA.After digestion, cells were zip tipped to remove any remnants of salt. ZipTip- A 
C18 ZipTip was activated by pipetting methanol 3 times up and down, and washed by 
pipetting 0.1% TFA 3 times. The sample was pipetted up and down 5 times, followed by 
washing with 0.1% TFA, and elution with 20 µl of 95% acetonitrile containing 0.1%  
TFA. Purified samples were prepared for mass spec. by combining 3 µl of sample with 3 
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µl of alpha-Cyano-4-hydroxycinnamic acid (CHCA, Sigma) to enable the detection of 
protein and peptides that are around 10 kDa or less. Of this mixture, 1 ul was carefully 
loaded on to a well on the MS plate and dried using a vacuum.  The mass spectrometer 
used was an Autoflex III MALDI-TOF/TOF MS (Bruker Biosciences Corporation, 
Billerica, MA).  This is used in combination with a matrix assisted laser 
desorption/ionization-time of flight instrument, MALDI-TOF.  Each fraction was initially 
analyzed by MS for peaks between 0-10,000 daltons in reflector mode and then in linear 
mode.  The spectra data was saved to FlexAnalysis and aligned in a group.  If specific 
peaks of high intensity were found, a LIFT was attempted to sequence the ion peaks.  MS 
fragmentation and sequencing by MS/MS was carried out to generate a table of 
sequenced proteins. 
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III.  RESULTS 
FRACTIONATION OF SNAKE VENOM BY FPLC 
 The first objective of the project was to establish a method for fractionation of 
snake venom proteins. FPLC was chosen as a ‘first pass’ method to separate proteins 
found in snake venom over more traditional column chromatography methods because of 
their cost and time constraints. Red Diamondback rattlesnake venom was injected into 
the FPLC and fractionated over a 20 minute time period (Figure 2). Multiple runs of the 
FPLC and the same venom suggested good reproducibility of the FPLC and cation 
column (Figure 3 A-D). Modifying the buffers in the FPLC did change the profile (Figure 
3) but it often showed less separation than the first ‘simple’ gradient used (Figure 3). 
SDS-PAGE analysis of the fractions using Coomassie staining suggested that there was 
some carryover on the column, potentially due to overloading with specific proteins that 
are in high abundance in the snake venom (Figure 4). However, there did appear to be 
some separation of larger and smaller proteins with the FPLC.  
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Figure 2: FPLC Fractionation of RDB rattlesnake venom. Three concentrations of RDB 
venom were fractionated by FPLC over the course of two days (A, B and C) with C being 
most concentrated. The venoms displayed a similar pattern over the run with slight shifts 
in retention time. The gradient from 100%A-0%B (0M NaCl, pH 8.0) to 100% B (1M 
NaCl, pH 8.0) and was the gradient used for the fractionation experiments in this project.   
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Figure 3: Observed fraction difference between venom A and B from 2011 vs. 2012 
Figure 3 shows differences in snake venom from one year to the next though from the 
same snake.  Venom in (A) was obtained in 2010 while venom in B was obtained in 2012. 
Gradients were similar to those used in Figure 2.  
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Figure 4: SDS-PAGE of FPLC purified snake venom. This gel was stained with 
Coomassie stain after running. The Marker lane is indicated with MW for each marker 
shown on the left. WV indicates whole venom and each fraction is numbered. Only 
fractions showing a positive trace on the FPLC were separated.  
Following the FPLC, snake venom fractions needed to be ‘desalted’ prior to 
adding them to cell culture media. If not, the media could become hyperosmotic and the 
changes in salt concentration could have a deleterious effect on the cells, regardless of the 
venom itself. The desalting was conducted using a 1000 dalton cutoff dialysis membrane 
stretched over the open end of an eppendorph tube. It was secured with a ‘dental’ type of 
rubber band (figure 5).  
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Figure 5: Steps for desalting FPLC fractions containing snake venom proteins. 
(A) Shows 29 mgs of Red Diamondback snake venom after dehydration on the speed vac. 
(B) shows all the parts necessary for desalting the snake venom fractions. (C) Trimming 
the eppendorph lid away (arrow). (D) Removing the edge where the lid was attached so 
that it does not puncture the membrane (Arrow) (E). Snake venom was pipetted into the 
eppendorph (F). (G) The membrane was stretched over the eppendorph and secured with 
a rubber band. (H) The eppendorph with venom and membrane was turned upside down 
in a 10 ml vial containing ddH2O.  
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SPECIFIC AIM 1 
Test the hypothesis that snake venom fractions can slow proliferation or cause cell death 
in lung or neuroblastoma cell lines. 
VENOM CYTOTOXICITY  
 The ability of snake venom fractions to cause cell death was analyzed by using 
MTT assay, LDH assay, propidium iodide assay, Hoechst and annexin staining.  
Neuro-2a Cell Death Assays 
 The first analysis for cell death was a simple visual examination of the cells on 
the phase contrast inverted microscope (Figure 6). The neuro-2a cells were treated with 
one concentration of RDB fractions for 4 hours followed by observation with the inverted 
phase microscope. Fractions 3, 4, 5, 8, 9 and 10 displayed characteristics similar to cell 
death, suggesting that the venom did work.  Other fractions appeared to not have an 
impact on cell proliferation or death.  
The Neuro-2A cells were treated with one concentration of RDB fractions from 0-
6 hours followed by the MTT assay. The MTT assay indicated some activity in wells 
containing fractions (Figure 4).  Fractions 5-10 either showed small activity or did not 
show activity. Two wells 4 and 12 showed a reverse trend, suggesting that the SV 
proteins had proliferative capabilities.  
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Figure 6: Neuro-2a cells post 4 hour fraction treatment. Cells were treated with a 10% 
solution of snake venom or water (control) in media. Cells were observed on 20X and 
pictures taken on an Optronics Magnafire CCD camera.   
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 The Neuro-2A cells were treated with increasing concentrations of RDB fractions 
for two hours followed by the MTT assay. The MTT assay indicated some activity in 
wells containing fractions (Figure 7).  Fractions 4, 5, 9, 10 11 and 14 showed no effect 
over time with the single dose of SV. However, there was an inhibitory trend in cell 
proliferation at several time periods in fraction 3. Likewise, there was a strong inhibition 
of proliferation over time in fractions 19 and 20. One fraction, 12 showed a reverse trend, 
suggesting that the SV proteins had proliferative capabilities. From this data, we chose to 
treat the cells for 2 hours with SV fractions in the rest of the experiments.  
The neuro-2A and lung cells were treated with RDB fractions for four hours 
followed by the LDH assay. The assay indicated high LDH activity in wells containing 
fractions 4, 5, 9, 12, 21 and 22 showed no response to the snake venom (Figure 5).  On 
the contrary, fractions 3, 11 and 14 showed an increase in MTT suggesting proliferation 
over the concentration curve. In contrast, fractions 19 and 20 showed inhibition 
indicating a slowing of proliferation or cell death.  
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Figure 7: Effect of snake venom fractions on neuro-2a cells over time. Following the 
appropriate treatment time with snake venom, the cells were assayed by an MTT assay. 
The Control cells are shown in the lower right corner. Absorbance was determined at 595 
nm on a Packard Fusion Plate reader. 
 
 
  
30	  
 
Figure 8: Effect of varying doses of snake venom fractions on neuro-2a cells. 
Following 4 hour treatment with snake venom, the cells were assayed by an MTT assay. 
Control cells lacking snake venom fractions are shown in the panel on the lower right.  
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 Neuro-2a cells were tested for necrosis using the LDH assay. LDH activity was 
observed in specific snake venom treated cells following the 2-hour incubation (Figure 9). 
The figure indicates that fractions 3, 5, 9, 13, and 21-24 had varying degrees of increased 
LDH activity. This firmly establishes that necrosis was ongoing in these cells. Since cell 
death was apparent at a very early stage, we did not test for apoptosis which requires a 
much longer time period to work. 
 
Fig. 9: LDH activity for each snake venom fraction was determined following 4 hour 
treatment with the fractions. LDH was assayed for each fraction. Note that the line went 
below zero on some fractions. This is due to the activity in the control wells being lower 
than the LDH in the treated cells. In these cases, subtraction of LDH gave a negative 
value.   
 Live cell membrane cannot be permeated by propidium iodide, therefore any 
positive fluorescence observed is indicative of cell death due to damaged cell membrane 
integrity.  Fractions 4, 11, 12, 13, 14, and 15 showed the highest amount of fluorescence 
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observed. PI fluorescence was also observed at a lower amount in other fractions 
suggesting that more fractions were affected than in the LDH assay.   
 
 
 
Figure 10: Effect of snake venom fractions on cell death. Cells were treated with snake 
venom fractions for 2 hours at the fixed concentration of snake venom, followed by 
fixation and analysis with propidium iodide (Nicoletti et al., 2006). PI staining of treated 
Neuro-2A showed differential uptake of PI into the cytosol and nucleus of different cells.    
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Cytotoxicity of Snake Venom on Lung Cells  
Lung cells were tested by two mechanisms for cytotoxicity, annexin staining and 
Hoecsht staining. Annexin resides on the inner plasma membrane of the cell and is not 
available for staining unless the membranes have been compromised and the cell is 
potentially in a death state. Figure 11 shows that venom fractions 3, 9, 14, 19, 20 and 21 
showed no or very low staining. Conversely, 4, 10, 11, 16 and 23 showed medium to 
strong staining indicating these cells were in a death state.  
Hoechst is a fluorescent dye that binds to the DNA of cells and fluoresces blue 
under UV light. When the lung cells were stained with Hoechst dye, the nuclei were all 
stained (Figure 12). The results clearly show size differences in the lung cell nuclei. 
Particularly, fractions 3, 4, 9, 11, 13, 14, 16, 21, and 23 appeared to be larger than the 
nuclei from control cells. Fractions 9, 10, 11 and 14 appeared to have assymetrical or 
disrupted nuclei. Fraction 20 appeared to have a strong, dense staining.  
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Fig. 11: Annexin staining of lung cells post treatment. Cells were treated with the SV 
fractions, fixed in 4% PFA and stained with annexin at 1:250 dilution. Images were taken 
of the cells and levels adjusted to the same threshold in Photoshop CS3. The final images 
were grouped in Adobe Illustrator.. 
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Fig. 12: Hoechst staining of lung cells post treatment. Images were captured on a Leica 
DMR fluorescence microscope and captured using a Leica camera. The Hoechst dye was 
found to stain all the nuclei, though some were brighter and some nuclei were larger than 
in control cells. 
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SPECIFIC AIM 2 
Test the hypothesis that cell functionality can be disrupted by specific snake venom 
proteins obtained by fractionation. 
FUNCTIONAL ANALYSIS OF NEURO-2A and LUNG CELLS 
Cellular functionality of neuro-2A cells as well as lung cells is tested and analyzed using 
the TLC assay and Chromogranin staining.  
CHROMOGRANIN STAINING 
 Chromogranin (CGA) is an endogenous protein resident in nearly every 
neuroendocrine cell [Lloyd, 1988]. To test the effect of snake venom on the neuro-2a cell 
line, which is a neuroendocrine type cell, we tested the ability of SV to perturb the 
intracellular targeting of chromogranin A to the regulated secretory granules.  Punctate 
granules were observed in cells treated with fractions 3, 5, 11, 14 and 21. The other 
fractions displayed CGA staining, however it was not observed in punctate granules, but 
instead was observed in a diffuse pattern suggestive of ER staining [Cool, 2009; Yan, 
2011].  
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Figure 13: Chromogranin staining of Neuro-2A cells post treatment with snake venom 
fractions. Cells were stained using a CGA antibody at 1:250 dilution.  
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TLC PLATE: 
 A TLC plate was run with lipids extracted from the media of cells following 
treatment with snake venom. Following the run, the TLC plates were sprayed with a 
solution of primuline and viewed on the Chemdoc MP+ under a 488 nm Dylight setting. 
TLC plate results suggested a strong lipid release by snake venom treated cells compared 
with the control cells (Figure 14). In table 3, specific lipid band ratios were found to be 
increased in band b, as well as specific other bands.  A graph (Figure 11) generated from 
the lipid values showed clearly in graph format the table data. 
 
Figure 14: TLC Plate analysis of lipids secreted from lung cells. The density for each 
band (a-g) was determined using the Image Lab software (Bio-Rad, Hercules CA). Each 
lane (1-12) represents the snake venom fractions and C1, C2 and C3 indicate the control 
cells that were not treated with venom. 
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Figure 15: TLC analysis of Secreted Surfactant Lipids. Lipids bands in each lane 
representing each snake venom were ratioed to the average of the control cells.  
  
 
 
!
Table&1:&&TLC&Plate&Analysis&of&Lipids&Secreted&from&Lung&Cells&in&Response&to&Snake&Venom&Fractions&
Band%No.% 3% 4% 9% C1% 11% 12% 14% C2% 15% 19% 20% C3% 21% 22%
a% 56 70 44 57 65 32 51 132 47 42 93 111 51 42 
b% 236 880 1753 67 1820 1056 1337 99 498 473 506 134 632 1776 
c% 49 83 97 72 66 62 211 177 123 178 80 51 60 121 
d% 64 730 53 127 122 610 162 90 509 168 102 83 108 216 
e% 123 151 119 114 160 118 129 145 113 115 123 41 157 139 
f% 72 326 320 85 95 121 63 169 92 88 114 46 79 123 
g% 177 250 108 96 104 203 73 118 182 138 106 86 242 251 
Grey&boxes&indicate&control&lanes&which&were&averaged.&&
Percent&of&control&=&(Density/Control)X100&
TLC&Plates&were&RPMPlates&run&in&a&51:32:9:5:3&(chloroform:methanol:acetic&
acid:acetone:ddH2O)&
TLC&Plate&lipids&were&stained&with&primuline.&
!
!
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SPECIFIC AIM 3 
Identify proteins in individual snake venom fractions and relate these to pathways 
involved in regulation of the cellular functions. 
PROTEIN IDENTIFICATION: 
 Once specific fractions causing changes in proliferation, cell death or cellular 
functionality were identified, mass spectrometry was used to specifically identify the 
causative proteins. Results from the MS indicate that fractions 4, 11, 12, 13, 14, and 15 
contain hemorrhagic toxin II, also known as hemorrhagic metalloproteinase HT-2.  All of 
the fractions causing the highest amount of cell death contained this particular protein as 
indicated by MASCOT searches. Other fractions contained other proteins of interest, 
such as a myotoxin, apoptosis inhibitor, and apoxin. Some of these fractions had no 
apparent effects on the cell lines and thus weren’t shown in every death assay or 
functionality assay. However, they should be examined more closely in the future.  
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Fig 16.  Peak analysis of SV fractions using MS following FPLC. Representative spectra 
are shown which have multiple peaks for proteins found in the snake venom fractions. 
Each of these spectra were digested with trypsin and subjected to LIFT MS/MS for 
protein sequencing. 
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Table 2: Snake venom sequences identified by MS sequencing.  
FPLC 
Frxn 
Mass Peaks m/z MS/MS sequences Protein/Protein 
Family 
Score 
4/5 23306 1192.4611 -SYEFSDASMR Hemorrhagic 
Toxin II 
(Ruberlysin) 
208 
4/11/18 23534 1192.574 R.  SYEFSDASMR.  Y Hemorrhagic 
metalloproteinase 
HT-2 (Ruberlysin) 
306 
9 58370 1037.455 -FWEDDGIR Apoxin I 53 
15/21 23306 1192.4611 -SYEFSDASMR Hemorrhagic 
Toxin II 
(Ruberlysin) 
104 
18/19 23534 1246.6848 -K.  NTLHSFGEWR. 
K 
Hemorrhagic 
Toxin HT-2 
(Ruberlysin) 
67 
18 14527 1246.6445 K.  LTNCDPKKDR. Y Phospholipase A2 
(Myotoxin I) 
22 
20 5328 930.5320 K.KGGHCFPK. T Myotoxin (Toxic 
Peptide C) 
64 
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IV.  DISCUSSION 
The main purpose of this study was to determine the effects of Red Diamondback 
rattlesnake venom on cancerous cell lines.  The top questions in consideration were: 1) 
Can snake venom factions cause cell death 2) what are the effects of those fractions on 
the cancer cells; 3) what are the causative proteins and their effect on cell functionality?  
To answer these questions, we examined the effects of snake venom on cell death and 
proliferation; cellular functionality; and identified proteins in the venom fractions.  
SPECIFIC AIM I 
Test the hypothesis that snake venom fractions can slow proliferation or cause cell death 
in lung or neuroblastoma cells. 
We observed that specific fractions had an inhibitory effect on cellular proliferation while 
other fractions appeared to cause proliferation. When cell death was assayed similar 
fractions appeared to give a strong reaction that resulted in cell death. These assays were 
used solely as a first pass screening effort to test the snake venom fractions prior to 
moving on with further tests. As such, they provided some overlapping and 
complimentary results as well as divergent results suggesting they may have an effect on 
the cells, but not the same effect always. While we talk about cell death in these assays, 
there could be an alternative answer to whether the cells were dying as a result of the 
snake venom interacting with cellular death processes. We could speculate that the 
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protease activity associated with the snake venom fractions was cleaving proteins 
expressed by the cells to specifically bind the cells to the culture dish surface. In this 
manner, the cells would be released, causing them to round up and die. Since they are 
adherent, the loss of their substrate to grow on would result in their death, and the venom 
would not have to enter or interact with other mechanistic functions of cell death. While 
it is interesting to speculate that these two cell lines might undergo cell death in the 
presence of specific fractions of snake venom, it is a long step towards the possibility that 
they could be used in a therapeutic role. Likewise, there is a potential benefit for a 
component in the snake venom fractions being used to help cells proliferate. This could 
be very important in situations like neuronal cell death or spinal cord injuries where the 
goal is to improve the outcome or initiate proliferation or regrowth of spinal cord cells. 
The venom component could be used to ‘seed’ the area and act as a type of chemokine to 
cause cells to proliferate and fill in the gap as an effective treatment for the condition.  
SPECIFIC AIM II 
The goal of this aim was to test the hypothesis that cell functionality could be disrupted 
by specific snake venom proteins obtained by fractionation. 
LIPID SECRETION 
 Aside from their role in exchanging oxygen and CO2, lung cells, particularly type 
II alveolar cells, are also responsible for secreting lipids as part of the surfactants used to 
help the lung function (Grgic, 2003). This is an especially critical area due to the 
potential for premature birth and the need to quickly increase fetal lung secretion of 
surfactants prior to birth. Corticosteroids have been given to pregnant women for more 
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than 30 years now to improve fetal lung maturity [O’Reilly, 1988; O’Reilly, 1989; 
O’Reilly, 1991; Vidaeff, 2004]. A standard dose of corticosteroid (dexamethasone or 
betamethasone) is 12 mg every 24 hours for 2 doses. However, in some circumstances, 
24 hours is all the time there is before delivery, and both doses have to be given within 
the 24 hour period. Thus, a non-lethal chemical that could speed this process would be an 
advantage over the corticosteroid. Our results are the first to show stimulation of lung 
surfactant release due to snake venom exposure. The results suggest a fast increase in 
production of the lipids and subsequent secretion of lipids from the cells. On the contrary, 
the results could also be explained by the lipids in the lamellar bodies being released as 
the cell membranes are permeablized. The results suggest that snake venom components 
might be able to cause changes in the lungs that could cause breathing difficulty in snake 
bite patients, especially if more surfactant is being secreted. This is potentially an 
interesting finding as it could allow for an increased production of surfactants in fetal 
lungs. It would be interesting to speculate that a snake venom component could someday 
be given to pregnant women to mature the fetal lungs in the cases of probably premature 
delivery. However, this may be more problematic due to the fact that giving snake venom 
to a pregnant woman might be of great concern to safety and ethical panels for human use. 
Nonetheless, some of these fractions should be tested in animal models to determine if 
they do have a future use as therapeutics for lung types of diseases.  
CHROMOGRANIN STAINING 
 Chromogranin A is produced in endocrine and neuroendocrine cells and is 
packaged in regulated secretory granules in these cells [Huttner, 198]. It is a sensitive 
endogenous marker for targeting proteins into the regulated secretory granules. When 
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there is a disruption in these cells, the regulated secretory proteins are not targeted 
efficiently or at all to these granules. Thus, chromogranin A staining in Neuro-2a cells is 
a useful marker for normal versus perturbed cell functioning. Staining treated Neuro-2a 
cells with chromogranin A antibodies showed that the cell function was compromised by 
SV fractions with six fractions showing the most change in cellular functionality. 
Endocrine disruption by snake venom is not normally a first concern but may be of 
concern later, if the patient survives the snake bite. However, if the patient lives, and 
depending on the location of the bite, some endocrine or neuroendocrine function may be 
compromised by the exposure to the venom.   
SPECIFIC AIM III 
Identify proteins in individual snake venom fractions and relate these to pathways 
involved in regulation of the cellular functions. 
MASS SPECTOMETRY 
 Based on the results obtained from the MS, we have determined a major protein 
residing in the venom of RDB snakes is Ruberlysin, also known as hemorrhagic toxin II. 
While this metalloproteinase was present in the venom, there were other proteins that 
were also identified; i.e, myotoxin and apoxin. The FPLC separation was not good 
enough to indicate whether one or a combination of all of these were causing a 
disturbance in cellular integrity as well as intercellular trafficking disturbances. As 
speculated previously, cell death, and even lipid release may have been a result of the 
release of the cells from the plate or lysing of the plasma membrane. With RDB venom 
being mainly a hemotoxic venom, it was no surprise to find this protein to be present in 
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huge amounts; however, its effects on neuro-2A cells was very interesting. The presence 
of other components such as myotoxin and especially apoxin, as well as numerous other 
proteins not identified in this study, but known to exist suggest that the venom may hold 
some interesting keys to unlocking cellular functions, that may someday be useful for 
therapeutic uses.    
CONCLUSION 
 Exposure to Red Diamondback Rattlesnake venom fractions causes cellular death 
in neuroblastoma and adenocarcinoma cells at a 1:8 dose ratio in 2-4 hours.  The 
exposure to these fractions damages the cell membrane of the neuro 2A and lung cells, 
leading to loss of axonal communication in neuronal cells and cell death in both cell 
types.  Apoptosis and necrosis are likely to be the form of death caused by RDB protein 
toxicity.  Assays such as the LDH and MTT indicated the effects of the multiple proteins 
present within each of those fractions.  Our data indicates high death rate in six of the 
fractions containing high amounts of the following proteins: Ruberlysin, phospholipase 
A2, as well as Apoxin I.  These proteins have indicated that they may play an important 
role in the apoptotic behavior amongst treated cancer cells.  Ruberlysin is mainly present 
in hemolytic venom and as named, is involved in the lysis and destruction of blood cells.  
However, in our study, ruberlysin has shown its involvement in the disruption of cellular 
integrity and apoptosis.  Phospholipase A2 is mainly involved in inflammation and may 
play a key role in cellular necrosis post treatment.  Apoxin I is an apoptosis inducing 
factor that has shown involvement in the apoptosis of fraction treated cells.  Six of the 
twelve RDB fractions showed the highest amount of the mentioned proteins present.  
However, further separation of these proteins was not possible, leading to a less than 
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accurate analysis of the functionality of these proteins in relation to themselves, one 
another and their effects on that of the treated cells.   
Obtained results give reason to further research on protein specific functionality 
of the RDB venom on various cancer lineage cells to obtain conclusive results.  Research 
into the therapeutic use of venoms should continued as a possible anti-cancer treatment 
form as well as for lung maturity and as an anti-inflammatory for surgical usage.  RDB 
venom is not as well researched as that of other venoms; this work would provide better 
understanding of the protein components of this specific type of venom.  It will provide a 
better understanding of cancer cells functionality in exposure to toxin inducing proteins 
as well as their possible application in cancer treatment as well.   
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